Pulse Biosciences Inc (PLSE)
9.97
-0.58
(-5.50%)
USD |
NASDAQ |
Jun 25, 16:00
9.97
0.00 (0.00%)
After-Hours: 20:00
Pulse Biosciences Research and Development Expense (Annual): 27.80M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 27.80M |
| December 31, 2022 | 20.84M |
| December 31, 2021 | 28.64M |
| December 31, 2020 | 26.44M |
| December 31, 2019 | 24.96M |
| Date | Value |
|---|---|
| December 31, 2018 | 17.25M |
| December 31, 2017 | 9.646M |
| December 31, 2016 | 5.506M |
| December 31, 2015 | 2.181M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
20.84M
Minimum
2022
28.64M
Maximum
2021
25.74M
Average
26.44M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Align Technology Inc | 346.83M |
| ThermoGenesis Holdings Inc | 1.284M |
| NeuroOne Medical Technologies Corp | 6.941M |
| SINTX Technologies Inc | 8.713M |
| Nutriband Inc | 1.960M |